Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Prediction Markets
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • Cannabis
  • General
  • Health Care
  • Markets
  • News
  • Top Stories

Cannabis-Based Medicine As A Potential Treatment For Psychosis, An Oxford University Study Says

By Joana Scopel
February 17, 5:51 PM
The Department of Psychiatry at the University of Oxford will conduct an international study to investigate whether cannabis-based medicine can treat psychosis.

JAZZ

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Analyst Says M&A Could Be A Negative Catalyst For This Aesthetic Company

By Vandana Singh
February 17, 2:14 PM
Needham has downgraded InMode Ltd (NASDAQ:INMD) from Buy to Hold with no price target. The analyst writes that the 1Q23 aesthetics patient…

INMD

Read More
1 minute read
  • Analyst Ratings
  • General
  • Health Care
  • Initiation
  • News
  • Price Target
  • Trading Ideas

Analyst Initiates Coverage of GE Healthcare, Says’ Path To Greatness Well-Paved’

By Vandana Singh
February 17, 2:08 PM
Mizuho Securities initiated coverage on GE Healthcare Technologies Inc (NASDAQ: GEHC) with a Buy rating and a price target of $90. Last month, General…

BIIB

Read More
1 minute read
  • General
  • Health Care
  • News

Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software

By Vandana Singh
February 17, 1:51 PM
Becton Dickinson and Co (NYSE: BDX) issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software.

BDX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Bristol Myers’ Opdivo Shows Improved Clinical Benefits In Bladder Cancer At Three Years

By Vandana Singh
February 17, 1:45 PM
Bristol-Myers Squibb Co (NYSE:BMY) announced three-year follow-up results from the Phase 3 CheckMate -274 Phase 3 trial of Opdivo compared to placebo…

BMY

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • News

Medtronic Scores CE Mark For Extravascular Defibrillator System For Abnormal Heart Rhythms

By Vandana Singh
February 17, 12:34 PM
The European authority has approved Medtronic plc’s (NYSE:MDT) Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan defibrillation…

MDT

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

Jasper Therapeutics Touts Encouraging Data From Briquilimab Conditioning In Inherited Bone Marrow Disorder

By Vandana Singh
February 17, 12:31 PM
Jasper Therapeutics Inc (NASDAQ:JSPR) announced that new follow-up data from its briquilimab (formerly known as JSP191) study as a conditioning agent…

JSPR

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

Stryker’s Q Guidance System Scores FDA Clearance For Cranial Applications

By Vandana Singh
February 17, 12:27 PM
Stryker Corporation (NYSE:SYK) announced that its Q Guidance System with Cranial Guidance Software received FDA510(k) clearance. The Q Guidance System…

SYK

Read More
1 minute read
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Shockwave Medical Shares Gain As Q4 Earnings Surpass Wall Street Expectations

By Vandana Singh
February 17, 12:01 PM
Shockwave Medical Inc (NASDAQ:SWAV) reported Q4 FY22 revenue of $144 million, an increase of 71% year-over-year, beating the consensus of…

SWAV

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News
  • Small Cap

Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate

By Vandana Singh
February 17, 6:47 AM
Pfizer Inc (NYSE:PFE) and Valneva SE (NASDAQ:VALN) announce that Pfizer, as the study sponsor, will discontinue a significant percentage of participants in the…

PFE

Posts navigation

Previous 1 … 16 17 18 … 563 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service